NRC Health (NRC) Q1 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning or good afternoon all, and welcome to the National Research Corporation First Quarter Earnings Call. My name is Adam and I'll be your operator today. If you'd like to ask a question during the Q&A portion of today's call, you may do so by pressing star followed by one on your telephone keypad. I will now hand the floor to Linda Stacey to begin. So Linda, please go ahead when you are ready. Thank you, Adam, and welcome everyone to National Research Corporation's 2024 First Quarter Earnings Call. My name is Linda Stacey, the company's Principal Financial Officer And joining me on the call today are Mark Scudder from our Executive Leadership Team and Helen Hurdy, our Chief Customer Officer. Before we continue, I'd like to point out this conference call includes forward-looking statements related to the company that involve risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the facts that could affect the company's future results, please see the company's filings with the Securities and Exchange Commission. With that, I'll turn it over to Mark. Thanks, Linda. Today we'll talk about markets and strategy, and then organizational changes and investments, and then our financial results and outlook. To start, we have big financial goals over the next several years. First, doubling our total addressable market through portfolio additions, acquisitions, and partnerships. Second, double-digit annual revenue growth. Third, expanding our margins. And fourth, creating significant value for investors. The leadership team is highly ali...